Article ; Online: Survie en vie réelle des patients ayant une fibrose pulmonaire idiopathique sous traitement anti-fibrosant.
Revue des maladies respiratoires
2023 Volume 40, Issue 5, Page(s) 371–381
Abstract: Introduction: Idiopathic pulmonary fibrosis (IPF) is an irreversible fibrosing disease with median survival at diagnosis of 2-5 years. That said, pirfenidone and nintedanib slow down the gradual decline in respiratory function. Clinical trials have ... ...
Title translation | Real-life survival of idiopathic pulmonary fibrosis with anti-fibrotic medication. |
---|---|
Abstract | Introduction: Idiopathic pulmonary fibrosis (IPF) is an irreversible fibrosing disease with median survival at diagnosis of 2-5 years. That said, pirfenidone and nintedanib slow down the gradual decline in respiratory function. Clinical trials have shown that while they are not curative, these drugs reduce mortality and increase survival time compared to placebo. This objective of this work was to compare the real-life survival of patients with IPF diagnosed at the Tours University Hospital depending on whether or not they took anti-fibrotic medication. Methods: This is a monocentric retrospective study involving 176 patients diagnosed with IPF starting from 1997. Out of these 176 patients, 100 were treated with anti-fibrotic agents and 76 did not receive any anti-fibrotic treatment. Results: Survival significantly increased in the group with anti-fibrotic medication, with median survival of 59 months [46-87] versus 39 months [29-65] (P=0.022). Predictive factors for death were neoplasia, IPF exacerbation and decreased DLCO. Conclusion: Our study corroborates the beneficial result observed in clinical trials by showing longer survival in patients using anti-fibrotic agents. |
MeSH term(s) | Humans ; Retrospective Studies ; Antifibrotic Agents ; Idiopathic Pulmonary Fibrosis/drug therapy ; Pyridones/therapeutic use ; Treatment Outcome |
Chemical Substances | Antifibrotic Agents ; Pyridones |
Language | French |
Publishing date | 2023-04-26 |
Publishing country | France |
Document type | English Abstract ; Journal Article |
ZDB-ID | 605743-3 |
ISSN | 1776-2588 ; 0301-0279 ; 0761-8425 |
ISSN (online) | 1776-2588 |
ISSN | 0301-0279 ; 0761-8425 |
DOI | 10.1016/j.rmr.2023.03.004 |
Database | MEDical Literature Analysis and Retrieval System OnLINE |
More links
Kategorien
In stock of ZB MED Cologne/Königswinter
Zs.A 1945: Show issues | Location: Je nach Verfügbarkeit (siehe Angabe bei Bestand) bis Jg. 1994: Bestellungen von Artikeln über das Online-Bestellformular Jg. 1995 - 2021: Lesesall (1.OG) ab Jg. 2022: Lesesaal (EG) |
|||
Zs.MO 94: Show issues |
Order via subito
This service is chargeable due to the Delivery terms set by subito. Orders including an article and supplementary material will be classified as separate orders. In these cases, fees will be demanded for each order.